Table 1.
Study questions on management of gynecologic cancers and mean quality ratings for physician and chatbot responses.
| Question | Mean quality rating* | ||
|---|---|---|---|
| Physician | ChatGPT | Bard | |
| Does PARP inhibitor therapy following chemotherapy lead to improved survival outcomes for patients with advanced stage ovarian cancer? | 5.0 | 2.7 | 3.3 |
| At the time of diagnosis of advanced stage ovarian cancer, is it better to begin chemotherapy or have surgery to remove the cancer? | 4.0 | 3.3 | 2.7 |
| Can some forms of ovarian cancer be treated without chemotherapy? | 3.7 | 2.0 | 2.0 |
| Is it safe to have a laparoscopic hysterectomy for cervical cancer? | 4.7 | 3.0 | 1.0 |
| When are PET-CT scans indicated for surveillance in gynecologic cancers? | 4.7 | 2.0 | 2.7 |
| What are the options for ovarian cancer screening and prevention in patients with a germline BRCA1 or BRCA2 mutation? | 3.7 | 2.7 | 3.3 |
| When would a patient be recommended radiation therapy after surgery for early-stage endometrial cancer? | 4.3 | 2.7 | 2.3 |
| Is neuropathy from taxane-induced neuropathy curable? | 4.3 | 4.0 | 3.3 |
| Which patients with vulvar cancer are eligible for sentinel lymph node mapping? | 2.7 | 3.7 | 4.3 |
| What is the role of biomarkers in treatment for endometrial cancer? | 5.0 | 3.7 | 2.7 |
*Quality scale was a 5-point Likert scale with 1 indicating very poor quality, 2: poor quality, 3: acceptable quality, 4: good quality, 5: very good quality.
PARP: poly (ADP-ribose) polymerase; PET-CT: Positron emission tomography–computed tomography.